Your browser doesn't support javascript.
loading
Pharmacokinetic equivalence of CT-P17 to high-concentration (100 mg/ml) reference adalimumab: A randomized phase I study in healthy subjects.
Yu, Kyung-Sang; Jang, In-Jin; Lim, Hyeong-Seok; Hong, Jang Hee; Kim, Min-Gul; Park, Min Kyu; Cho, Doo-Yeoun; Park, Min Soo; Chung, Jae Yong; Ghim, Jong-Lyul; Lee, SeungHwan; Yoon, Seok Kyu; Kwon, In Sun; Lee, Sang Joon; Kim, Sung Hyun; Bae, Yun Ju; Cha, Jung Bin; Furst, Daniel E; Keystone, Edward; Kay, Jonathan.
Afiliación
  • Yu KS; Seoul National University College of Medicine and Hospital, Seoul, Korea.
  • Jang IJ; Seoul National University College of Medicine and Hospital, Seoul, Korea.
  • Lim HS; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
  • Hong JH; Chungnam National University Hospital, Daejeon, Korea.
  • Kim MG; College of Medicine, Jeonbuk National University, Jeonbuk, Korea.
  • Park MK; Chungbuk National University Hospital, Cheongju, Korea.
  • Cho DY; CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • Park MS; Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Chung JY; Seoul National University Bundang Hospital, Seongnam, Korea.
  • Ghim JL; Inje University Busan Paik Hospital, Busan, Korea.
  • Lee S; Seoul National University College of Medicine and Hospital, Seoul, Korea.
  • Yoon SK; Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
  • Kwon IS; Chungnam National University Hospital, Daejeon, Korea.
  • Lee SJ; Celltrion, Inc., Incheon, Korea.
  • Kim SH; Celltrion, Inc., Incheon, Korea.
  • Bae YJ; Celltrion, Inc., Incheon, Korea.
  • Cha JB; Celltrion, Inc., Incheon, Korea.
  • Furst DE; University of California, Los Angeles, California, USA.
  • Keystone E; University of Washington, Seattle, Washington, USA.
  • Kay J; University of Florence, Florence, Italy.
Clin Transl Sci ; 14(4): 1280-1291, 2021 07.
Article en En | MEDLINE | ID: mdl-33503313

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Adalimumab / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biosimilares Farmacéuticos / Adalimumab / Inhibidores del Factor de Necrosis Tumoral Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos